Common Stock, Shares, Outstanding of Nascent Biotech Inc. from 31 Mar 2014 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nascent Biotech Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Mar 2014 to 30 Jun 2024.
  • Nascent Biotech Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 172,202,165, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 172,202,165 +28,565,387 +20% 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q1 2024 170,594,165 +38,829,817 +29% 31 Mar 2024 10-Q 14 Aug 2024 2025 Q1
Q4 2023 168,729,565 +46,683,393 +38% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 166,735,430 +48,540,346 +41% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 143,636,778 +26,571,103 +23% 30 Jun 2023 10-Q 18 Aug 2023 2024 Q1
Q1 2023 131,764,348 +20,451,173 +18% 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 122,046,172 +14,317,997 +13% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 118,195,084 +10,466,909 +9.7% 30 Sep 2022 10-Q 10 Nov 2022 2023 Q2
Q2 2022 117,065,675 +9,337,500 +8.7% 30 Jun 2022 10-Q 09 Aug 2022 2023 Q1
Q1 2022 111,313,175 +6,479,092 +6.2% 31 Mar 2022 10-K/A 03 Jul 2023 2023 FY
Q4 2021 107,728,175 +16,398,021 +18% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 107,728,175 +40,547,484 +60% 30 Sep 2021 10-Q 04 Nov 2021 2022 Q2
Q2 2021 107,728,175 +44,934,568 +72% 30 Jun 2021 10-Q 12 Aug 2021 2022 Q1
Q1 2021 104,834,083 +59,943,821 +134% 31 Mar 2021 10-K 15 Jun 2022 2022 FY
Q4 2020 91,330,154 +55,369,284 +154% 31 Dec 2020 10-Q 09 Feb 2021 2021 Q3
Q3 2020 67,180,691 +33,407,721 +99% 30 Sep 2020 10-Q 16 Nov 2020 2021 Q2
Q2 2020 62,793,607 +29,298,137 +87% 30 Jun 2020 10-Q 07 Aug 2020 2021 Q1
Q1 2020 44,890,262 +12,243,627 +38% 31 Mar 2020 10-K 08 Jul 2021 2021 FY
Q4 2019 35,960,870 +4,821,272 +15% 31 Dec 2019 10-Q 11 Feb 2020 2020 Q3
Q3 2019 33,772,970 +3,240,113 +11% 30 Sep 2019 10-Q 18 Nov 2019 2020 Q2
Q2 2019 33,495,470 +4,952,175 +17% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q1
Q1 2019 32,646,635 +4,893,270 +18% 31 Mar 2019 10-K 22 Jun 2020 2020 FY
Q4 2018 31,139,598 +3,877,792 +14% 31 Dec 2018 10-Q 13 Feb 2019 2019 Q3
Q3 2018 30,532,857 +3,401,081 +13% 30 Sep 2018 10-Q 05 Nov 2018 2019 Q2
Q2 2018 28,543,295 +4,496,606 +19% 30 Jun 2018 10-Q 06 Aug 2018 2019 Q1
Q1 2018 27,753,365 +4,461,067 +19% 31 Mar 2018 10-K 12 Jul 2019 2019 FY
Q4 2017 27,261,806 +5,383,391 +25% 31 Dec 2017 10-Q 31 Jan 2018 2018 Q3
Q3 2017 27,131,776 +5,286,661 +24% 30 Sep 2017 10-Q 03 Nov 2017 2018 Q2
Q2 2017 24,046,689 +2,262,624 +10% 30 Jun 2017 10-Q 09 Aug 2017 2018 Q1
Q1 2017 23,292,298 +1,674,733 +7.7% 31 Mar 2017 10-K 29 Jun 2018 2018 FY
Q4 2016 21,878,415 +477,300 +2.2% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q3
Q3 2016 21,845,115 +883,963 +4.2% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q2
Q2 2016 21,784,065 +3,719,465 +21% 30 Jun 2016 10-Q 09 Aug 2016 2017 Q1
Q1 2016 21,617,565 +4,052,965 +23% 31 Mar 2016 10-K 29 Jun 2017 2017 FY
Q4 2015 21,401,115 +4,091,515 +24% 31 Dec 2015 10-Q 19 Feb 2016 2016 Q3
Q3 2015 20,961,152 30 Sep 2015 10-Q 05 Nov 2015 2016 Q2
Q2 2015 18,064,600 30 Jun 2015 10-Q 30 Jul 2015 2016 Q1
Q1 2015 17,564,600 +10,564,400 +151% 31 Mar 2015 10-K 14 Jul 2016 2016 FY
Q4 2014 17,309,600 31 Dec 2014 10-Q 13 Feb 2015 2015 Q3
Q1 2014 7,000,200 31 Mar 2014 10-K 02 Jul 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.